Skip to content

CoolFit BRZ-AP1-066-000Recalls & reported problems

Zeltiq Aesthetics, Inc. · CoolFit · Class 2

1 open recall names this device. See the recall details and contact the manufacturer or your healthcare provider.

Adverse event reports
1
Deaths reported
0
Injuries reported
1
Recalls naming it
1

Summary

The FDA's MAUDE database contains 1 adverse event report that list this exact device (DI 00816417020216), received between Aug 11, 2023 and Aug 11, 2023 — classified as 1 injury.

1 FDA recall record name this device's identifier, 1 still open.

Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. How this data works · Data updated Oct 13, 2026.

Recalls naming this device

  1. Jun 9, 2022Open, Classified

    Executing a voluntary discontinuation and removal of parallel plate applicators due to an increase complaint rate for adverse event Paradoxical Hyperplasia (HP) during the 2019 to 2021 timeframe.

    Z-1350-2022 · Root cause: Unknown/Undetermined by firm · FDA record ↗

Most reported problems

Device problems

  • Adverse Event Without Identified Device or Use Problem1

Patient problems

  • Hyperplasia1

Recent adverse event reports

The 1 most recent of 1 reports, in the reporter's own words as published by the FDA.

  • InjuryAug 11, 2023Adverse Event Without Identified Device or Use Problem; Adverse Event Without Identified Device or Use Problem

    ALLERGAN AESTHETICS RECEIVED A REPORT OF A MALE PATIENT TREATED WITH COOLSCULPTING TO THE RIGHT AND LEFT LOWER ABDOMEN ON (B)(6) 2015 USING COOLFIT APPLICATOR WHO DEVELOPED PARADOXICAL HYPERPLASIA AFTER TREATMENT

    Patient problems: Hyperplasia

    MAUDE report 17509907 ↗

Other Dermal Cooling Pack/Vacuum/Massager devices

All Dermal Cooling Pack/Vacuum/Massager devices →

Sources: FDA GUDID, MAUDE and Medical Device Recalls via openFDA. openFDA data is not validated for clinical or regulatory use.